Summary

HNY Research projects that the Irritable Bowel Syndrome (IBS) market size will grow from 6320.77 Million USD in 2025 to 16590.51 Million USD by 2031, at an estimated CAGR of 17.45%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 1385.51 Million USD, the Europe market size was 889.96 Million USD, and the Asia market size was 1295.76 Million USD.
This report presents a detailed and holistic analysis of the global Irritable Bowel Syndrome (IBS) market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Irritable Bowel Syndrome (IBS) manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals

By Type
IBS-D Drug
IBS-C Drug
Others

By Application
Women
Men

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
1.4 Market Analysis by Type
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2026-2031
1.4.2 IBS-D Drug
1.4.3 IBS-C Drug
1.4.4 Others
1.5 Market by Application
1.5.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2026-2031
1.5.2 Women
1.5.3 Men
1.6 Study Objectives
1.7 Overview of Global Irritable Bowel Syndrome (IBS) Market
1.7.1 Global Irritable Bowel Syndrome (IBS) Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome (IBS)
2.2 Industry Chain Structure of Irritable Bowel Syndrome (IBS)
3 Market Competition by Manufacturers
3.1 Global Irritable Bowel Syndrome (IBS) Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Irritable Bowel Syndrome (IBS) Average Price by Manufacturers (2020-2025)
4 Irritable Bowel Syndrome (IBS) Regional Market Analysis
4.1 Irritable Bowel Syndrome (IBS) Production by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Production by Regions (2020-2025)
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue by Regions
4.2 Irritable Bowel Syndrome (IBS) Consumption by Regions
4.3 North America Irritable Bowel Syndrome (IBS) Market Analysis
4.3.1 North America Irritable Bowel Syndrome (IBS) Production
4.3.2 North America Irritable Bowel Syndrome (IBS) Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Irritable Bowel Syndrome (IBS) Import and Export
4.4 East Asia Irritable Bowel Syndrome (IBS) Market Analysis
4.4.1 East Asia Irritable Bowel Syndrome (IBS) Production
4.4.2 East Asia Irritable Bowel Syndrome (IBS) Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Irritable Bowel Syndrome (IBS) Import & Export
4.5 Europe Irritable Bowel Syndrome (IBS) Market Analysis
4.5.1 Europe Irritable Bowel Syndrome (IBS) Production
4.5.2 Europe Irritable Bowel Syndrome (IBS) Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Irritable Bowel Syndrome (IBS) Import & Export
4.6 South Asia Irritable Bowel Syndrome (IBS) Market Analysis
4.6.1 South Asia Irritable Bowel Syndrome (IBS) Production
4.6.2 South Asia Irritable Bowel Syndrome (IBS) Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Irritable Bowel Syndrome (IBS) Import & Export
4.7 Southeast Asia Irritable Bowel Syndrome (IBS) Market Analysis
4.7.1 Southeast Asia Irritable Bowel Syndrome (IBS) Production
4.7.2 Southeast Asia Irritable Bowel Syndrome (IBS) Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Irritable Bowel Syndrome (IBS) Import & Export
4.8 Middle East Irritable Bowel Syndrome (IBS) Market Analysis
4.8.1 Middle East Irritable Bowel Syndrome (IBS) Production
4.8.2 Middle East Irritable Bowel Syndrome (IBS) Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Irritable Bowel Syndrome (IBS) Import & Export
4.9 Africa Irritable Bowel Syndrome (IBS) Market Analysis
4.9.1 Africa Irritable Bowel Syndrome (IBS) Production
4.9.2 Africa Irritable Bowel Syndrome (IBS) Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Irritable Bowel Syndrome (IBS) Import & Export
4.10 Oceania Irritable Bowel Syndrome (IBS) Market Analysis
4.10.1 Oceania Irritable Bowel Syndrome (IBS) Production
4.10.2 Oceania Irritable Bowel Syndrome (IBS) Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Irritable Bowel Syndrome (IBS) Import & Export
4.11 South America Irritable Bowel Syndrome (IBS) Market Analysis
4.11.1 South America Irritable Bowel Syndrome (IBS) Production
4.11.2 South America Irritable Bowel Syndrome (IBS) Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Irritable Bowel Syndrome (IBS) Import & Export
5 Irritable Bowel Syndrome (IBS) Sales Market by Type (2020-2031)
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2020-2025)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2026-2031)
6 Irritable Bowel Syndrome (IBS) Consumption Market by Application(2020-2031)
6.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2020-2025)
6.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Irritable Bowel Syndrome (IBS) Business
7.1 Bausch Health
7.1.1 Bausch Health Company Profile
7.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Specification
7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Allergan
7.2.1 Allergan Company Profile
7.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Specification
7.2.3 Allergan Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Takeda
7.3.1 Takeda Company Profile
7.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Specification
7.3.3 Takeda Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Sucampo Pharmaceuticals (Mallinckrodt)
7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Profile
7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Specification
7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Sebela Pharmaceuticals Inc
7.5.1 Sebela Pharmaceuticals Inc Company Profile
7.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Specification
7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Astellas Pharmaceuticals
7.6.1 Astellas Pharmaceuticals Company Profile
7.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Specification
7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Irritable Bowel Syndrome (IBS) (2026-2031)
8.2 Global Forecasted Revenue of Irritable Bowel Syndrome (IBS) (2026-2031)
8.3 Global Forecasted Price of Irritable Bowel Syndrome (IBS) (2020-2031)
8.4 Global Forecasted Production of Irritable Bowel Syndrome (IBS) by Region (2026-2031)
8.4.1 North America Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.3 Europe Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.7 Africa Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.9 South America Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Irritable Bowel Syndrome (IBS) Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.2 East Asia Market Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.3 Europe Market Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Countriy
9.4 South Asia Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.5 Southeast Asia Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.6 Middle East Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.7 Africa Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.8 Oceania Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.9 South America Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
9.10 Rest of the world Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer